Related Experiment Video
Updated: Aug 29, 2025

09:30
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.5K
A biochip based on shell-isolated Au@MnO2 nanoparticle array-enhanced fluorescence effect for simple and sensitive
Yingzhi Zhang1, Jiayuan Fan1, Jing Zhao1
1Research Center for Analytical Sciences, Northeastern University, Shenyang, 110819, PR China.
Biosensors & Bioelectronics
|September 4, 2022
Summary
This study introduces a novel metal-enhanced fluorescence (MEF) biochip for simple and sensitive exosome detection. The new method significantly improves exosome detection limits, showing promise for noninvasive liquid biopsy applications.
Area of Science:
- Biomarker Discovery
- Nanotechnology
- Analytical Chemistry
Background:
- Exosomes are crucial biomarkers for liquid biopsy due to their molecular cargo.
- Current exosome detection methods often rely on complex nucleic acid amplification.
- A need exists for simpler, more sensitive exosome detection techniques.
Purpose of the Study:
- To develop a simple and highly sensitive method for exosome assay using metal-enhanced fluorescence (MEF).
- To utilize a shell-isolated Au@MnO2 nanoparticle array for enhanced exosome detection.
- To establish a novel strategy for exosome-based liquid biopsy.
Main Methods:
- Designed a metal-enhanced fluorescence (MEF) biochip utilizing a shell-isolated Au@MnO2 nanoparticle array.
- Employed a chain displacement reaction for exosome signal conversion to DNA signals.
- Achieved dual signal amplification through signal conversion and MEF amplification.
Main Results:
- The MEF biochip demonstrated high sensitivity for exosome detection with a limit of 4.5 × 10^3 particles/μL.
- Sensitivity was enhanced approximately thirtyfold compared to methods without MEF.
- The method successfully distinguished breast cancer patients from healthy individuals.
Conclusions:
- The developed MEF biochip offers a simple, sensitive, and stable platform for exosome detection.
- This strategy represents the first application of MEF for exosome assay.
- The technology shows significant potential for noninvasive liquid biopsy, particularly in cancer diagnostics.

